New ultrasonic needle yields samples 2–3 times larger, potentially reshaping cancer diagnostics
Peer-Reviewed Publication
Updates every hour. Last Updated: 29-May-2026 13:15 ET (29-May-2026 17:15 GMT/UTC)
Invariant natural killer T (iNKT) cells are promising for cancer immunotherapy because they can coordinate broader immune responses, but sourcing enough functional cells is challenging. In a recent study, researchers from Japan showed that combining stem cell-derived iNKT cells with an immune-activating lipid compound can strongly suppress tumors in mice by training the body’s own T cells to recognize and remember cancer. These findings point to a more effective and scalable form of immunotherapy.
OAKLAND, Calif., May 7, 2026 -- A study published today in The Permanente Journal sheds light on what’s driving physicians to leave clinical practice early — and how those reasons are shifting. Researchers from the American Medical Association (AMA) analyzed survey responses from 971 clinically inactive physicians across all specialties who completed residency between 2000 and 2022. Their findings offer insights into why physicians are stepping away from patient care — or not entering the clinical workforce at all — especially as the nation faces a growing physician shortage.